chrX-53196844-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004187.5(KDM5C):​c.2823A>G​(p.Ser941Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,207,911 control chromosomes in the GnomAD database, including 2 homozygotes. There are 477 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., 53 hem., cov: 25)
Exomes 𝑓: 0.0012 ( 1 hom. 424 hem. )

Consequence

KDM5C
NM_004187.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.00400

Publications

1 publications found
Variant links:
Genes affected
KDM5C (HGNC:11114): (lysine demethylase 5C) This gene is a member of the SMCY homolog family and encodes a protein with one ARID domain, one JmjC domain, one JmjN domain and two PHD-type zinc fingers. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling. Mutations in this gene have been associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
KDM5C Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability Claes-Jensen type
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-53196844-T-C is Benign according to our data. Variant chrX-53196844-T-C is described in ClinVar as [Benign]. Clinvar id is 211248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.004 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00138 (157/113510) while in subpopulation AMR AF = 0.0034 (37/10880). AF 95% confidence interval is 0.00254. There are 1 homozygotes in GnomAd4. There are 53 alleles in the male GnomAd4 subpopulation. Median coverage is 25. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 53 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KDM5CNM_004187.5 linkc.2823A>G p.Ser941Ser synonymous_variant Exon 19 of 26 ENST00000375401.8 NP_004178.2 P41229-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KDM5CENST00000375401.8 linkc.2823A>G p.Ser941Ser synonymous_variant Exon 19 of 26 1 NM_004187.5 ENSP00000364550.4 P41229-1

Frequencies

GnomAD3 genomes
AF:
0.00138
AC:
157
AN:
113459
Hom.:
1
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.000352
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.00639
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000702
Gnomad FIN
AF:
0.00251
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00133
Gnomad OTH
AF:
0.00195
GnomAD2 exomes
AF:
0.00131
AC:
224
AN:
171337
AF XY:
0.00145
show subpopulations
Gnomad AFR exome
AF:
0.000163
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.00482
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00300
Gnomad NFE exome
AF:
0.00124
Gnomad OTH exome
AF:
0.00330
GnomAD4 exome
AF:
0.00119
AC:
1306
AN:
1094401
Hom.:
1
Cov.:
32
AF XY:
0.00118
AC XY:
424
AN XY:
360161
show subpopulations
African (AFR)
AF:
0.0000760
AC:
2
AN:
26320
American (AMR)
AF:
0.00135
AC:
47
AN:
34830
Ashkenazi Jewish (ASJ)
AF:
0.00638
AC:
123
AN:
19290
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30043
South Asian (SAS)
AF:
0.000355
AC:
19
AN:
53564
European-Finnish (FIN)
AF:
0.00281
AC:
113
AN:
40217
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4115
European-Non Finnish (NFE)
AF:
0.00112
AC:
937
AN:
840101
Other (OTH)
AF:
0.00139
AC:
64
AN:
45921
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00138
AC:
157
AN:
113510
Hom.:
1
Cov.:
25
AF XY:
0.00149
AC XY:
53
AN XY:
35654
show subpopulations
African (AFR)
AF:
0.000351
AC:
11
AN:
31340
American (AMR)
AF:
0.00340
AC:
37
AN:
10880
Ashkenazi Jewish (ASJ)
AF:
0.00639
AC:
17
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3586
South Asian (SAS)
AF:
0.000703
AC:
2
AN:
2844
European-Finnish (FIN)
AF:
0.00251
AC:
16
AN:
6374
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00133
AC:
71
AN:
53368
Other (OTH)
AF:
0.00193
AC:
3
AN:
1554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00171
Hom.:
13
Bravo
AF:
0.00151

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 24, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 02, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Oct 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KDM5C-related disorder Benign:1
Apr 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
9.6
DANN
Benign
0.58
PhyloP100
-0.0040
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143955805; hg19: chrX-53226026; COSMIC: COSV104428173; API